90 related articles for article (PubMed ID: 18813237)
1. Survival from brain tumours in England and Wales up to 2001.
Short SC
Br J Cancer; 2008 Sep; 99 Suppl 1(Suppl 1):S102-3. PubMed ID: 18813237
[No Abstract] [Full Text] [Related]
2. Survival from brain tumours in England and Wales up to 2001.
Rachet B; Mitry E; Quinn MJ; Cooper N; Coleman MP
Br J Cancer; 2008 Sep; 99 Suppl 1(Suppl 1):S98-101. PubMed ID: 18813276
[No Abstract] [Full Text] [Related]
3. Survival analysis for adult glioma in England and Wales.
Tseng MY; Tseng JH
J Formos Med Assoc; 2005 May; 104(5):341-8. PubMed ID: 15959601
[TBL] [Abstract][Full Text] [Related]
4. Brain tumours in children.
Holmberg L
Acta Paediatr; 2009 Oct; 98(10):1550-2. PubMed ID: 19650785
[No Abstract] [Full Text] [Related]
5. Survival analysis of children with primary malignant brain tumors in England and Wales: a population-based study.
Tseng JH; Tseng MY
Pediatr Neurosurg; 2006; 42(2):67-73. PubMed ID: 16465074
[TBL] [Abstract][Full Text] [Related]
6. [Developments in therapy of malignant gliomas in the last 30 years].
Bamberg M
Krankenpfl J; 2004; 42(5-6):155-6. PubMed ID: 15527219
[No Abstract] [Full Text] [Related]
7. Survival analysis of 459 adult patients with primary spinal cancer in England and Wales: a population-based study.
Tseng JH; Tseng MY
Surg Neurol; 2007 Jan; 67(1):53-8; discussion 58. PubMed ID: 17210300
[TBL] [Abstract][Full Text] [Related]
8. [Progress in prognosis for patients with gliomas].
Kumabe T; Tominaga T
Nihon Rinsho; 2005 Sep; 63 Suppl 9():293-7. PubMed ID: 16201537
[No Abstract] [Full Text] [Related]
9. Non-surgical therapy for malignant brain tumours.
Moseley RP; Coakham HB
Br J Hosp Med; 1990 Jun; 43(6):453-8. PubMed ID: 2364239
[TBL] [Abstract][Full Text] [Related]
10. Effects of socioeconomic and geographic variations on survival for adult glioma in England and Wales.
Tseng JH; Merchant E; Tseng MY
Surg Neurol; 2006 Sep; 66(3):258-63; discussion 263. PubMed ID: 16935629
[TBL] [Abstract][Full Text] [Related]
11. Outcome of secondary high-grade glioma in children previously treated for a malignant condition: a study of the Canadian Pediatric Brain Tumour Consortium.
Carret AS; Tabori U; Crooks B; Hukin J; Odame I; Johnston DL; Keene DL; Freeman C; Bouffet E;
Radiother Oncol; 2006 Oct; 81(1):33-8. PubMed ID: 16973227
[TBL] [Abstract][Full Text] [Related]
12. [Brain tumors. Mainly glial tumors in adults].
Kosteljanetz M
Ugeskr Laeger; 2002 Jun; 164(23):3017-20. PubMed ID: 12082850
[No Abstract] [Full Text] [Related]
13. [Perspectives in diagnosis and management of malignant gliomas].
Psimaras D; Delattre JY
Cancer Radiother; 2008 Nov; 12(6-7):695-700. PubMed ID: 18829366
[TBL] [Abstract][Full Text] [Related]
14. Quality-adjusted survival analysis of malignant glioma. Patients treated with twice-daily radiation (RT) and carmustine: a report of Radiation Therapy Oncology Group (RTOG) 83-02.
Murray KJ; Nelson DF; Scott C; Fischbach AJ; Porter A; Farnan N; Curran WJ
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):453-9. PubMed ID: 7852106
[TBL] [Abstract][Full Text] [Related]
15. [Metronidazole in the large split-dose concentrated irradiation of malignant gliomas].
Kachkov IA; Liass FM; Pelevina II; Konradov SA
Med Radiol (Mosk); 1980 Aug; 25(8):5-7. PubMed ID: 7401975
[No Abstract] [Full Text] [Related]
16. Complexities, pitfalls, and strategies for evaluating brain tumor therapies.
Kaplan RS
Curr Opin Oncol; 1998 May; 10(3):175-8. PubMed ID: 9619351
[No Abstract] [Full Text] [Related]
17. The role of tregs in human glioma patients and their inhibition with a novel STAT-3 inhibitor.
Heimberger AB; Kong LY; Abou-Ghazal M; Reina-Ortiz C; Yang DS; Wei J; Qiao W; Schmittling RJ; Archer GE; Sampson JH; Hiraoka N; Priebe W; Fuller GN; Sawaya R
Clin Neurosurg; 2009; 56():98-106. PubMed ID: 20214040
[No Abstract] [Full Text] [Related]
18. Malignant glioma management.
Salcman M
Neurosurg Clin N Am; 1990 Jan; 1(1):49-63. PubMed ID: 2135973
[TBL] [Abstract][Full Text] [Related]
19. Using mathematical modeling to predict survival of low-grade gliomas.
Alvord EC; Swanson KR
Ann Neurol; 2007 May; 61(5):496; author reply 496-7. PubMed ID: 17252546
[No Abstract] [Full Text] [Related]
20. Assessing HRQOL: a neglected issue for high-grade glioma.
Efficace F; Bottomley A
Lancet Oncol; 2003 Jan; 4(1):11-2. PubMed ID: 12517534
[No Abstract] [Full Text] [Related]
[Next] [New Search]
